Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 13, 2021
Patent Application Number
16874485
Date Filed
May 14, 2020
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
